Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial : Clinical Journal of the American Society of Nephrology

Journal Logo

Original Article: Cystic Kidney Disease

Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD

A Randomized Crossover Trial

Kramers, Bart J.1; Koorevaar, Iris W.1; van Gastel, Maatje D.A.1; van Goor, Harry2; Hallows, Kenneth R.3,4; Heerspink, Hiddo L.5; Li, Hui3,4; Leonhard, Wouter N.6; Peters, Dorien J.M.6; Qiu, Jiedong2; Touw, Daan J.5,7; Gansevoort, Ron T.1; Meijer, Esther1

Author Information
CJASN 17(4):p 507-517, April 2022. | DOI: 10.2215/CJN.11260821
  • Buy
  • Infographic
  • SDC

Abstract

Copyright © 2022 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid